Evidence map›Paper›PMID 37262110›Full record

ArticleVirulence2023

Patterns of hepatitis b virus immune escape and pol/rt mutations across clinical cohorts of patients with genotypes a, e and occult hepatitis b infection in Nigeria: A multi-centre study.

Oluwadamilola G Osasona, Oluwatosin O Oguntoye, Abiola O Arowosaye, Lukman O Abdulkareem, Moses O Adewumi, Christian Happi, Onikepe Folarin

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Virulence, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Oluwadamilola G OsasonaAfrican Centre of Excellence for the Genomics of Infectious Diseases, Redeemers University, Ede, Nigeria.ORCID 0000-0003-4887-9336
Oluwatosin O OguntoyeDepartment of Medicine, Federal Teaching Hospital, Ido-Ekiti, Nigeria.
Abiola O ArowosayeDepartment of Virology, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Lukman O AbdulkareemDepartment of Internal Medicine, University of Abuja Teaching Hospital, Gwagwalada, Abuja, Nigeria.
Moses O AdewumiDepartment of Virology, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Christian HappiAfrican Centre of Excellence for the Genomics of Infectious Diseases, Redeemers University, Ede, Nigeria.
Onikepe FolarinAfrican Centre of Excellence for the Genomics of Infectious Diseases, Redeemers University, Ede, Nigeria.
Redeemer's University · NGUniversity of Ibadan · NGEkiti State University · NGUniversity of Abuja Teaching Hospital · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatitis B virus (HBV) immune escape and Pol/RT mutations account for HBV immunoprophylactic, therapeutic, and diagnostic failure globally. Little is known about circulating HBV immune escape and Pol/RT mutants in Nigeria. This study focused on narrowing the knowledge gap of the pattern and prevalence of the HBV mutants across clinical cohorts of infected patients in southwestern Nigeria. Ninety-five enrollees were purposively recruited across clinical cohorts of HBV-infected patients with HBsAg or anti-HBc positive serological outcome and occult HBV infection. Total DNA was extracted from patients' sera. HBV S and Pol gene-specific nested PCR amplification was carried out. The amplicons were further sequenced for serotypic, genotypic, phylogenetic, and mutational analysis. HBV S and Pol genes were amplified in 60 (63.2%) and 19 (20%) of HBV isolates, respectively. All the sixty HBV S gene and 14 of 19 Pol gene sequences were exploitable. The ayw4 serotype was predominant (95%) while ayw1 serotype was identified in 5% of isolates. Genotype E predominates in 95% of sequences, while genotype A, sub-genotype A3 was observed in 5%. Prevalence of HBV IEMs in the "a" determinant region was 29%. Commonest HBV IEM was S113T followed by G145A and D144E. The Pol/RT mutations rtV214A and rtI163V among others were identified in this study. This study provided data on the occurrence of existing and new HBV IEMs and Pol gene mutations in Nigeria.

Indexed as

Hepatitis BHepatitis B, ChronicDNA, ViralGenes, polGenotypeHepatitis B virusHumansMutationNigeriaPhylogenyDNA, ViralHBVImmune escape mutationoccult hepatitis B infection, clinical, NigeriaPol mutations

Identifiers

PMID37262110
PMCPMC10237049
OpenAlexW4379056820

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.